Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tandem Autologous PBSCT After High Dose Paclitaxel Followed by ICE for Lung Cancer
NCT00003284Phase 2Unknown
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Start
- Jan 1998
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, ifosfamide, carboplatin, etoposide in lung cancer, sponsored by Herbert Irving Comprehensive Cancer Center. Status: unknown.
02
Drugs
paclitaxelifosfamidecarboplatinetoposide
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT00003284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003284.